News

In the current pandemic situation, we know that trial participants may have concerns or questions about taking their trial treatment and attending follow-up appointments. We have provided some general ...

Click here to view the poster ...

A pre-planned feasibility analysis (based on run-in data from 2253 participants across all tumour cohorts), suggested that aspirin is well-tolerated after radical therapy, with a low burden of toxicit ...

A reminder to all UK and ROI sites:  Please ensure you are posting CRFs to the correct address.  MRC CTU has been based at 2nd Floor, 90 High Holborn, London, WC1V 6LJ since October 2017.  Post going ...

2018 was our best year yet for recruitment to the gastro-oesophageal cohort! Many thanks to all of you who have contributed to this success with your hard work.As we move forward into 2019 we would li ...